Terms: = Breast cancer AND SOX2, MGC2413, 6657, ENSG00000181449, MCOPS3, P48431, ANOP3
435 results:
1. Long non-coding RNA sox2OT in tamoxifen-resistant breast cancer.
Lee J; Kim EA; Kang J; Chae YS; Park HY; Kang B; Lee SJ; Lee IH; Park JY; Park NJ; Jung JH
BMC Mol Cell Biol; 2024 Apr; 25(1):12. PubMed ID: 38649821
[TBL] [Abstract] [Full Text] [Related]
2. Hinokitiol Inhibits breast cancer Cells In Vitro Stemness-Progression and Self-Renewal with Apoptosis and Autophagy Modulation via the CD44/Nanog/sox2/Oct4 Pathway.
Chiang YF; Huang KC; Chen HY; Hamdy NM; Huang TC; Chang HY; Shieh TM; Huang YJ; Hsia SM
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612715
[TBL] [Abstract] [Full Text] [Related]
3. Exposure to di-2-ethylhexyl phthalate and breast neoplasm incidence: A cohort study.
Tang L; Wang Y; Yan W; Zhang Z; Luo S; Wen Q; Wang S; Zhou N; Chen Q; Xu Y
Sci Total Environ; 2024 May; 926():171819. PubMed ID: 38508268
[TBL] [Abstract] [Full Text] [Related]
4. miR-29a-KLF4 signaling inhibits breast tumor initiation by regulating cancer stem cells.
Zhao Q; Shang Y; Lü J; Liu Y; Wang T; Li D; Li J; Lu Y; Wang Z; Yu Z
Int Immunopharmacol; 2024 Mar; 130():111797. PubMed ID: 38442582
[TBL] [Abstract] [Full Text] [Related]
5. Role of hydroxymethylglutharyl-coenzyme A reductase in the induction of stem-like states in breast cancer.
Marks MP; Giménez CA; Isaja L; Vera MB; Borzone FR; Pereyra-Bonnet F; Romorini L; Videla-Richardson GA; Chasseing NA; Calvo JC; Vellón L
J Cancer Res Clin Oncol; 2024 Feb; 150(2):106. PubMed ID: 38418798
[TBL] [Abstract] [Full Text] [Related]
6. Are embryonic stem cell markers and ALDH1A1 relevant in the context of breast cancer estrogen positivity?
Mousa NA; Hussein A; Elemam NM; Mohammed G; Elwany M; Basha T; AlHammadi AA; Majzob RS; Talaat IM
Cancer Med; 2024 Feb; 13(3):e7004. PubMed ID: 38400679
[TBL] [Abstract] [Full Text] [Related]
7. Synthesis of Self Permeable Antisense PMO Using C5-Guanidino-Functionalized Pyrimidines at the 5'-End Enables sox2 Downregulation in Triple Negative breast cancer Cells.
Das A; Gupta S; Shaw P; Sinha S
Mol Pharm; 2024 Mar; 21(3):1256-1271. PubMed ID: 38324380
[TBL] [Abstract] [Full Text] [Related]
8. Sphingomyelin synthase 2 promotes the stemness of breast cancer cells via modulating NF-κB signaling pathway.
Feng H; Dong Y; Chen K; You Z; Weng J; Liang P; Shi F
J Cancer Res Clin Oncol; 2024 Jan; 150(2):46. PubMed ID: 38285090
[TBL] [Abstract] [Full Text] [Related]
9. SIX1 amplification modulates stemness and tumorigenesis in breast cancer.
Guo L; Li F; Liu H; Kong D; Chen C; Sun S
J Transl Med; 2023 Nov; 21(1):866. PubMed ID: 38031089
[TBL] [Abstract] [Full Text] [Related]
10. Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma.
Augustin RC; Newman S; Li A; Joy M; Lyons M; Pham MP; Lucas P; Smith K; Sander C; Isett B; Davar D; Najjar YG; Zarour HM; Kirkwood JM; Luke JJ; Bao R
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37857525
[TBL] [Abstract] [Full Text] [Related]
11. Mechanisms of breast cancer Stem Cell Specification and Self-Renewal Mediated by Hypoxia-Inducible Factor 1.
Semenza GL
Stem Cells Transl Med; 2023 Dec; 12(12):783-790. PubMed ID: 37768037
[TBL] [Abstract] [Full Text] [Related]
12. Epigenetic reprogramming of a distal developmental enhancer cluster drives sox2 overexpression in breast and lung adenocarcinoma.
Abatti LE; Lado-Fernández P; Huynh L; Collado M; Hoffman MM; Mitchell JA
Nucleic Acids Res; 2023 Oct; 51(19):10109-10131. PubMed ID: 37738673
[TBL] [Abstract] [Full Text] [Related]
13. Biological evaluation of [4-(4-aminophenyl)-1-(4-fluorophenyl)-1H-pyrrol-3-yl](3,4,5-trimethoxyphenyl)methanone as potential antineoplastic agent in 2D and 3D breast cancer models.
Mazzoccoli C; Crispo F; Laurenzana I; Pietrafesa M; Sisinni L; Lerose R; Telesca D; Milella MR; Liu T; Della Sala G; Sebastiani J; Silvestri R; La Regina G
Arch Pharm (Weinheim); 2023 Oct; 356(10):e2300354. PubMed ID: 37603378
[TBL] [Abstract] [Full Text] [Related]
14. Estrogen-Related Receptor Alpha (ERRα) Promotes cancer Stem Cell-Like Characteristics in breast cancer.
Muduli K; Prusty M; Pradhan J; Samal AP; Sahu B; Roy DS; Reddy KS; Elangovan S
Stem Cell Rev Rep; 2023 Nov; 19(8):2807-2819. PubMed ID: 37584854
[TBL] [Abstract] [Full Text] [Related]
15. Overexpression of sox2 Gene by Histone Modifications: sox2 Enhances Human Prostate and breast cancer Progression by Prevention of Apoptosis and Enhancing Cell Proliferation.
Kar S; Niharika ; Roy A; Patra SK
Oncology; 2023; 101(9):591-608. PubMed ID: 37549026
[TBL] [Abstract] [Full Text] [Related]
16. A phenol amine molecule from Salinivenus iranica acts as the inhibitor of cancer stem cells in breast cancer cell lines.
Safarpour A; Ebrahimi M; Fazeli SAS; Amoozegar MA
Sci Rep; 2023 Aug; 13(1):12669. PubMed ID: 37542193
[TBL] [Abstract] [Full Text] [Related]
17. Circular RNA_0000326 accelerates breast cancer development via modulation of the miR-9-3p/YAP1 axis.
Xue XL; Zhao S; Xu MC; Li Y; Liu WF; Qin HZ
Neoplasma; 2023 Jun; 70(3):430-442. PubMed ID: 37498061
[TBL] [Abstract] [Full Text] [Related]
18. The deformation of cancer cells through narrow micropores holds the potential to regulate genes that impact cancer malignancy.
Choi JS; Lee SH; Park HB; Chun C; Kim Y; Kim KH; Weon BM; Kim DH; Kim HJ; Lee JH
Lab Chip; 2023 Aug; 23(16):3628-3638. PubMed ID: 37448298
[TBL] [Abstract] [Full Text] [Related]
19. MCL1 Inhibition Overcomes the Aggressiveness Features of Triple-Negative breast cancer MDA-MB-231 Cells.
Pratelli G; Carlisi D; Di Liberto D; Notaro A; Giuliano M; D'Anneo A; Lauricella M; Emanuele S; Calvaruso G; De Blasio A
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446326
[TBL] [Abstract] [Full Text] [Related]
20. Loss of miR-6844 alters stemness/self-renewal and cancer hallmark(s) markers through CD44-JAK2-STAT3 signaling axis in breast cancer stem-like cells.
Prajapati KS; Kumar S
J Cell Biochem; 2023 Aug; 124(8):1186-1202. PubMed ID: 37436061
[TBL] [Abstract] [Full Text] [Related]
[Next]
